RadNet, Inc. (RDNT) Financials

RDNT Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 3.9 billion 2.5 billion
Dec. 31, 2025 3.8 billion 2.4 billion
Sept. 30, 2025 3.7 billion 2.4 billion
June 30, 2025 3.5 billion 2.3 billion

RDNT Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 22.3 million ?
Dec. 31, 2025 -230.9 million 8.3 million
Sept. 30, 2025 -7.6 million 9.0 million
June 30, 2025 67.4 million 8.7 million

RDNT Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 -33.5 million
Dec. 31, 2025 9.9 million
Sept. 30, 2025 13.9 million
June 30, 2025 14.5 million

RDNT Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 455.3 million 1.1 billion 781.3 million
Dec. 31, 2025 767.2 million 1.1 billion 707.0 million
Sept. 30, 2025 804.7 million 1.1 billion 751.3 million
June 30, 2025 833.2 million 1.1 billion 738.3 million

RDNT Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 77.1 million
Dec. 31, 2025 75.2 million
Sept. 30, 2025 74.7 million
June 30, 2025 74.1 million

RDNT Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 69.9 million - - -
Dec. 31, 2025 315.0 million 3.6 million - -
Sept. 30, 2025 60.4 million 3.6 million - -
June 30, 2025 52.9 million - - -

RDNT Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 575.6 million 592.0 million
Dec. 31, 2025 547.7 million 471.8 million
Sept. 30, 2025 522.9 million 450.4 million
June 30, 2025 498.2 million 429.1 million

RDNT Revenue by Segment

Graph available only for paid members. Upgrade to see it.

RDNT

Price: $51.87

52 week price:
50.76
85.84

Payout Ratio Range:
-40.08%
82.75%

Earnings Per Share: -0.17 USD

Exchange: NGM

Sector: Healthcare

Industry: Diagnostics & Research

Country: United States

Volume: 93400

Ebitda: 32.2 million

Market Capitalization: 4.1 billion

Links: